InMed Pharmaceuticals Inc (INM) — Capital Reinvestment Ratio

Latest as of June 2005: 0.23x

InMed Pharmaceuticals Inc (INM) has a Capital Reinvestment Ratio of 0.23x as of June 2005, meaning it reinvests 0% of its operating cash flow ($265.71K) in capital expenditures ($60.44K). See INM net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.23x

Capex / Operating Cash Flow

Operating Cash Flow

$265.71K

USD

Capital Expenditures

$60.44K

USD

Data as of

Jun 2005

Most recent filing

Annual Capital Reinvestment Ratio for InMed Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for InMed Pharmaceuticals Inc from None to None. For live market cap and broader valuation context, see market value of InMed Pharmaceuticals Inc.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow